Krka lists in Warsaw, eyes €100m treasury sale
Slovenian generic drug firm Krka completed a dual listing on the Warsaw Stock Exchange this week in a move that might be a precursor to a liquidity-enhancing sale of some or all of its treasury shares.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts